The Clorox Company (NYSE:CLX) Shares Sold by Tucker Asset Management LLC

Tucker Asset Management LLC reduced its holdings in The Clorox Company (NYSE:CLX) by 20.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,213 shares of the company’s stock after selling 312 shares during the period. Tucker Asset Management LLC’s holdings in Clorox were worth $197,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also recently bought and sold shares of CLX. Integral Investment Advisors Inc. increased its stake in shares of Clorox by 4.1% in the 4th quarter. Integral Investment Advisors Inc. now owns 1,718 shares of the company’s stock worth $279,000 after acquiring an additional 67 shares during the last quarter. HCR Wealth Advisors raised its stake in Clorox by 1.0% during the fourth quarter. HCR Wealth Advisors now owns 6,870 shares of the company’s stock worth $1,116,000 after purchasing an additional 68 shares during the period. Sound View Wealth Advisors Group LLC boosted its holdings in Clorox by 6.1% in the 4th quarter. Sound View Wealth Advisors Group LLC now owns 1,345 shares of the company’s stock valued at $218,000 after purchasing an additional 77 shares during the last quarter. Brooklyn Investment Group grew its stake in shares of Clorox by 163.8% in the 4th quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock valued at $25,000 after buying an additional 95 shares during the period. Finally, Global X Japan Co. Ltd. increased its holdings in shares of Clorox by 3.0% during the 4th quarter. Global X Japan Co. Ltd. now owns 3,272 shares of the company’s stock worth $531,000 after buying an additional 95 shares during the last quarter. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Clorox Trading Up 0.4 %

NYSE:CLX opened at $146.18 on Friday. The stock has a market capitalization of $18.01 billion, a price-to-earnings ratio of 39.94, a PEG ratio of 2.62 and a beta of 0.45. The Clorox Company has a 1 year low of $127.60 and a 1 year high of $171.37. The stock has a fifty day moving average price of $151.34 and a two-hundred day moving average price of $159.09. The company has a debt-to-equity ratio of 20.52, a quick ratio of 0.60 and a current ratio of 0.94.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Monday, February 3rd. The company reported $1.55 EPS for the quarter, beating the consensus estimate of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same period in the previous year, the business earned $2.16 earnings per share. As a group, sell-side analysts anticipate that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, May 9th. Investors of record on Wednesday, April 23rd will be paid a $1.22 dividend. This represents a $4.88 dividend on an annualized basis and a yield of 3.34%. The ex-dividend date of this dividend is Wednesday, April 23rd. Clorox’s payout ratio is currently 133.33%.

Analyst Ratings Changes

A number of research analysts have commented on CLX shares. StockNews.com cut shares of Clorox from a “buy” rating to a “hold” rating in a research report on Sunday, January 5th. Barclays decreased their price objective on shares of Clorox from $140.00 to $139.00 and set an “underweight” rating on the stock in a report on Thursday. Royal Bank of Canada reiterated a “sector perform” rating and issued a $150.00 target price on shares of Clorox in a report on Thursday, January 30th. DA Davidson lowered their price target on Clorox from $171.00 to $169.00 and set a “neutral” rating for the company in a research report on Wednesday, February 5th. Finally, Wells Fargo & Company boosted their price objective on Clorox from $157.00 to $161.00 and gave the company an “equal weight” rating in a report on Tuesday, February 4th. Three equities research analysts have rated the stock with a sell rating, ten have given a hold rating and one has given a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $159.50.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.